Diffusion Pharmaceuticals Inc (DFFN)

0.851 -0.06  -6.77% NASDAQ Sep 18, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/13/2020 Earnings Diffusion Pharmaceuticals Inc Third Quarter Earnings Results for 2020
08/10/2020 Earnings Diffusion Pharmaceuticals Inc Second Quarter Earnings Results for 2020
05/11/2020 Earnings Diffusion Pharmaceuticals Inc First Quarter Earnings Results for 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.diffusionpharma.com
  • Investor Relations URL: N/A
  • HQ State/Province: Virginia
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Nov. 13, 2020
  • Last Earnings Release: Aug. 10, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM); Phase II pancreatic cancer; and metastatic brain cancer. Geographically business activity of the firm is functioned through the region of the US.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.